US Patent Issued to Abbott Diabetes Care on Sept. 9 for "Application interface and display control in an analyte monitoring environment" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,411,930, issued on Sept. 9, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Application interface and display control in an analyte monitoring environment" was invented by Glenn Berman (Alameda, Calif.), Nathan Crouther (San Francisco), Michael R. Love (Pleasanton, Calif.) and Mark Sloan (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the...